There are currently 2035 clinical trials in Chicago, Illinois looking for participants to engage in research studies. Trials are conducted at various facilities, including Northwestern University, Rush University Medical Center, University of Chicago and University of Chicago Comprehensive Cancer Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Impact of Sensor Technology in Knee OA
Recruiting
OBJECTIVES: Physical activity has been established as an important component of rehabilitation for knee osteoarthritis (OA), and is often guided by a physical therapist.(1) Physical therapy for knee OA typically involves 1-3 sessions with a licensed physical therapist per week, for up to 12 weeks. These sessions can take a lot of time and effort for subjects, particularly when travel times are considered. Remote patient monitoring is an emerging treatment method which can help to reduce the nee... Read More
Gender:
All
Ages:
Between 40 years and 75 years
Trial Updated:
01/24/2022
Locations: Shirley Ryan AbilityLab, Chicago, Illinois
Conditions: Knee Osteoarthritis
Study of Acalabrutinib (ACP-196) in Combination With Venetoclax (ABT-199), With and Without Obinutuzumab (GA101) Versus Chemoimmunotherapy for Previously Untreated CLL
Recruiting
The purpose of this study is to evaluate the efficacy and safety of acalabrutinib in combination with venetoclax and acalabrutinib in combination with venetoclax with and without obinutuzumab compared to chemoimmunotherapy in subjects with previously untreated CLL.
Gender:
All
Ages:
Between 18 years and 130 years
Trial Updated:
01/14/2022
Locations: Research Site, Chicago, Illinois +1 locations
Conditions: Chronic Lymphocytic Leukemia
The EMPOWER Study: Endometriosis Diagnosis Using microRNA
Recruiting
Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal risk study in women undergoing laparoscopy, laparotomy or other pelvic surgical procedure for endometriosis, infertility or another benign gynecological indication. Participants will undergo 2 study visi... Read More
Gender:
Female
Ages:
Between 18 years and 49 years
Trial Updated:
01/11/2022
Locations: Northwestern Medicine, Chicago, Illinois
Conditions: Endometriosis
A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness
Recruiting
The purpose of this study is to determine the feasibility of producing artificial vision in persons with blindness. Study participants will have wireless electrical stimulators implanted into the cortical vision processing areas of their brains. The ability of the participants to perceive artificial vision in response to electrical stimulation will be assessed.
Gender:
All
Ages:
Between 19 years and 70 years
Trial Updated:
01/09/2022
Locations: Illinois Institue of Technology, Chicago, Illinois
Conditions: Ocular Injury, Optic Nerve Diseases, Photoreceptor Degeneration, Blindness,Acquired
Prediction of Outcomes After Surgery for Unruptured Intracranial Aneurysms
Recruiting
Accurate preoperative identification of patients at high risk for adverse outcomes would be clinically advantageous, as it would allow enhanced resource preparation, better surgical decision-making, enhanced patient education and informed consent, and potentially even modification of certain modifiable risk factors. The aim of the Prediction of adverse events after microsurgery for intracranial unruptured aneurysms (PRAEMIUM) study is therefore to develop and externally validate a clinically app... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/05/2021
Locations: University of Illinois, Chicago, Illinois
Conditions: Aneurysm, Brain
Mimic-game & Groove: A TeleXercise Intervention to Get Active & Get Healthy
Recruiting
The composite effect of reduced balance, cognition, gait abnormalities/gait disturbances, and physical activity in older adults leads to fear of falling and decreased participation in daily activities, resulting in reduced cardiovascular fitness and deconditioning. Although many conventional balance and strength training programs have been implemented for older adults, these adults do not receive adequate practice dosage to make significant improvements, most likely due to lack of adherence to t... Read More
Gender:
All
Ages:
Between 55 years and 85 years
Trial Updated:
11/23/2021
Locations: University of Illinois at Chicago, Chicago, Illinois
Conditions: Healthy Older Adults
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
Recruiting
The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples to other researchers and organizations (eg, CBTN, DIPG Registry, COG).
Gender:
All
Ages:
All
Trial Updated:
11/03/2021
Locations: Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
Conditions: Pediatric Cancer
Anesthesia Consent Process
Recruiting
Currently at University of Chicago Medical Center (UCMC) consent for anesthesia is obtained verbally by qualified anesthesia providers. Later this year, we will be moving to a written informed consent form for anesthesia that must be signed by patients before proceeded with elective surgery. We aim to study patient satisfaction and retention of information presented before and after this change is made. After consent for anesthesia is obtained, study personnel will approach patients >= 18 years... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/19/2021
Locations: University of Chicago Medical Center, Chicago, Illinois
Conditions: Anesthesia Risks, Anesthesia Consent, Anesthesia, Consent Retention, Patient Satisfaction
A Study to Evaluate the Safety and Efficacy of RQC for AMD
Recruiting
To evaluate the safety and efficacy of resveratrol, quercetin, and curcumin in combination (RQC) over 2 years in patients with age-related macular degeneration (AMD).
Gender:
All
Ages:
Between 50 years and 90 years
Trial Updated:
09/20/2021
Locations: Zaparackas M.D. & Knepper M.D. Ph.D., Ltd, Chicago, Illinois
Conditions: Age-related Macular Degeneration
Examining Health Literacy in Biorepository Consents
Recruiting
Previous research has shown that most parents would allow their child's leftover blood to be included in a de-identified biorepository using opt-out consent in an outpatient setting. In a pilot study to evaluate Pediatric Intensive Care Unit (PICU) parents' preferences and comprehension of a written opt-in consent to include their child's sample in a biorepository, the investigators showed 19% of parents did not agree to participate in the Biobank, more than the 8.7% reported in other settings.... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
07/03/2021
Locations: Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois
Conditions: Pediatric, Critical Illness, Consent
Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation
Recruiting
This pilot study has been designed to investigate the safety of pembrolizumab treatment for disease relapse following allogeneic stem cell transplant (alloSCT). Pembrolizumab will be administered at a fixed dose of 200 mg IV every 3 weeks. Approximately 12-26 patients with relapsed MDS, AML, or mature B cell (B-NHL, cHL) malignancies that have relapsed following alloSCT will be enrolled on this trial. Pembrolizumab treatment will be administered for up to 24 months, provided that neither disease... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
06/29/2021
Locations: University of Chicago, Chicago, Illinois
Conditions: Classical Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Myelodysplastic Syndromes
Multi-Center Study to Evaluate the Efficacy and Safety of Sildenafil Cream (3.6%) in Premenopausal Patients With Female Sexual Arousal Disorder
Recruiting
This study is looking to minimize side effects, while maintaining and potentially improving the therapeutic benefit to patients suffering from Female Sexual Arousal Disorder by providing a topical preparation of Sildenafil locally to the vulvar-vaginal tissue.
Gender:
Female
Ages:
21 years and above
Trial Updated:
06/24/2021
Locations: Great Lakes Clinical Trials, Chicago, Illinois
Conditions: Female Sexual Arousal Disorder